Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.

Abstract:

:Topotecan is indicated in the treatment of advanced-stage ovarian cancers refractory to prior platinum-based regimen. The aim of this study was to compare the standard therapeutic strategy with a novel strategy of weekly administration of topotecan. The primary endpoints were dose density and overall tolerance. This retrospective cohort study included patients with ovarian cancer in relapse. During a first period (1998-2001), 24 patients received the standard topotecan dose of 1.5 mg/m(2)/day for 5 consecutive days with a 3-week interval between each treatment course. During a second period (2003-2006), 21 patients received a weekly topotecan dose of 4 mg/m(2) for 3 weeks out of every 4. Grades III and IV haematological toxicities were more frequent with the standard strategy (p < 0.05), even after adjustment of the prescription of erythropoietin and G-CSF. With the weekly strategy, an increase in dose density and a reduction in the number of delayed doses were observed. No significant difference between the 2 strategies was found in terms of response to the treatment and specific survival. This study suggests that the weekly administration of topotecan 4 mg/m(2), for 3 weeks out of every 4, results in a better maintenance of dose density and a reduction in haematological toxicity.

journal_name

Oncology

journal_title

Oncology

authors

Largillier R,Valenza B,Ferrero JM,Novo C,Creisson A,Lesbats G,Mari V,Hebert C,Chamorey E

doi

10.1159/000127384

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

177-84

issue

3-4

eissn

0030-2414

issn

1423-0232

pii

000127384

journal_volume

73

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Effects of cycloheximide on chromatin-bound and -unbound PCNA in HeLa cells.

    abstract::We examined the effects of cycloheximide on the amount of chromatin-bound and -unbound PCNA subpopulations in HeLa cells. The chromatin-bound PCNA content decreased rapidly in the presence of cycloheximide, whereas the reduction of the total amount of PCNA was minimal even 24 h after the treatment with cycloheximide. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227500

    authors: Sasaki K,Kurose A,Uesugi N,Kato A

    更新日期:1995-09-01 00:00:00

  • Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia.

    abstract::Acute myeloid leukemia (AML) originates from self-renewing leukemic stem cells (LSCs), an ultimate therapeutic target in AML. Eradication of LSCs should be a critical and efficient therapeutic approach for the cure of AML. T-cell immunoglobulin mucin-3 (TIM-3) is expressed in most types of AML LSCs, but not in normal ...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000431062

    authors: Kikushige Y,Miyamoto T

    更新日期:2015-01-01 00:00:00

  • Presence of anti-gamma-FA-reactive antigens in spontaneous and carcinogen-induced malignancies of experimental animals.

    abstract::Immunochemical analysis of various tumors, representing 12 different tissue sites of origin, revealed a gamma-fetal antigen(gamma-FA)-like component in 17 of 23 malignant neoplasms of the mouse. This antigen was identified in extracts of spontaneous and carcinogen-induced murine tumors as well as in extracts of hepati...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225584

    authors: Higgins PJ,Tong C,Borenfreund E

    更新日期:1981-01-01 00:00:00

  • Early observations on the administration of Lonidamine in cancer patients.

    abstract::Lonidamine was studied in advanced cancer patients. The drug was given orally by single or repeated administrations. Single doses ranged from 150 to 450 mg. Repeated administrations were performed with progressively increasing doses: 450-900 mg daily. Lonidamine lacked severe toxic effects after both single and prolon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225891

    authors: Barduagni A,Barduagni M,Di Lauro L,Nardi M,Gallo Curcio C,Tonachella R,Ciottoli GB,Delle Chiaie S

    更新日期:1984-01-01 00:00:00

  • Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.

    abstract:BACKGROUND:Ethnic disparities in cancers are associated with variability in clinical outcomes. We present a Surveillance Epidemiology and End RESULTS (SEER)-based outcome analysis of multiethnic Waldenström's macroglobulinemia (WM) patients. METHODS:Adult WM patients diagnosed in 1992 or later (n = 3,175) were analyze...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000360992

    authors: Ailawadhi S,Kardosh A,Yang D,Cozen W,Patel G,Alamgir MA,Chanan-Khan AA

    更新日期:2014-01-01 00:00:00

  • Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

    abstract::Calcitriol (1,25-dihydroxycholecalciferol) has antiproliferative and/or proapoptotic effects on many cell types and the glucocorticoid dexamethasone enhances these effects. We have shown that calcitriol modulates several key signaling proteins involved in differentiation, proliferation and apoptosis in tumor-derived m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000098872

    authors: Flynn G,Chung I,Yu WD,Romano M,Modzelewski RA,Johnson CS,Trump DL

    更新日期:2006-01-01 00:00:00

  • Efficacy of Vinorelbine Monotherapy as Third- or Further-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.

    abstract:BACKGROUND:The survival rate of patients with lung cancer has increased significantly over the years, but there has been no further progress in third- or fourth-line therapy. We investigated the efficacy and tolerability of monotherapy with weekly vinorelbine, a semi-synthetic vinca alkaloid, in advanced non-small-cell...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000502343

    authors: Kang DH,Kim JO,Jung SS,Park HS,Chung C,Park D,Lee JE

    更新日期:2019-01-01 00:00:00

  • Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.

    abstract:OBJECTIVE:We evaluated the psychometric properties of the Korean version of the European Organization for Research and Treatment of Cancer QLQ-PR25 when applied to Korean prostate cancer (PC) patients. METHODS:A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen d...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000355689

    authors: Park J,Shin DW,Yun SJ,Park SW,Jeon SS,Kwak C,Kwon TG,Kim HJ,Ahn H

    更新日期:2013-01-01 00:00:00

  • Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.

    abstract:OBJECTIVES:To assess the feasibility and efficacy of intensity-modulated radiation implemented with helical tomotherapy image-guided with daily megavoltage computed tomography for head and neck cancer. METHODS:Between May 2010 and May 2013, 72 patients were treated with curative intent. The median age was 64 years, wi...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000489217

    authors: Santa Cruz O,Tsoutsou P,Castella C,Khanfir K,Anchisi S,Bouayed S,Matzinger O,Ozsahin M

    更新日期:2018-01-01 00:00:00

  • Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.

    abstract::Methyl-CCNU (NSC-95441) was administered to patients with malignant melanoma in a split dose schedule. Nausea and vomiting were eliminated as clinical problems during therapy. Response rate to the drug seemed somewhat lower than the average of three previously reported disease-oriented phase II trials, though the diff...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225178

    authors: Wittes RE,Hong WK,Gatchell L,Krakoff IH,Golbey RB

    更新日期:1977-01-01 00:00:00

  • Restricted activity of serum blocking factors related to a common tumour antigen in mice.

    abstract::Mice of four different inbred strains (CBA, Balb/c, C57Bl/6 and DBA/2), bearing different transplanted tumours (methylcholanthrene-induced sarcomas, B16 melanoma and P-815 mastocytoma), were tested for cellular immune reactivity to the synthetic encephalitogenic peptide of human myelin basic protein by the leucocyte a...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225732

    authors: Yong WK,Halliday WJ

    更新日期:1983-01-01 00:00:00

  • Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter.

    abstract::Quercetin, a mutagenic but noncarcinogenic flavonoid, inhibited the increased incorporation of inorganic phosphate into phospholipids of human embryo fibroblasts induced by 12-O-tetradecanoylphorbol-13-acetate (TPA), a potent tumor promoter. Quercetin also inhibited TPA-induced increases of sugar transport and RNA syn...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225805

    authors: Nishino H,Nishino A,Iwashima A,Tanaka K,Matsuura T

    更新日期:1984-01-01 00:00:00

  • Protein accumulation in cultures of hepatic tumor cells exposed to dimethylsulfoxide.

    abstract::The effect of the differentiation-inducing agent dimethylsulfoxide (DMSO) on the protein composition of hepatic tumor cells was evaluated using the BW77-1 line of murine hepatoma cells previously determined to be DMSO-inducible for enhanced liver function. DMSO-mediated suppression of BW77-1 proliferation was accompan...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225850

    authors: Higgins PJ

    更新日期:1984-01-01 00:00:00

  • HER2 as a prognostic factor in breast cancer.

    abstract::HER2 amplification/overexpression is a marker of poor prognosis in breast cancer. The prognostic impact of HER2 positivity is lower in node-negative compared with node-positive women. The only significant, independent prognostic factors in breast cancer are node status, HER2 status and menopausal status. HER2-positive...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000055404

    authors: Ménard S,Fortis S,Castiglioni F,Agresti R,Balsari A

    更新日期:2001-01-01 00:00:00

  • Attenuation by the GABA receptor agonist baclofen of experimental carcinogenesis in rat colon by azoxymethane.

    abstract::The effects of the gamma-amino-n-butyric acid (GABA)A receptor agonist muscimol, and the GABAB receptor agonist baclofen, on colon carcinogenesis induced by azoxymethane in Wistar rats were tested. Administration of either muscimol or baclofen had no influence on the incidence of colon tumors at week 30. However, almo...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227048

    authors: Tatsuta M,Iishi H,Baba M,Taniguchi H

    更新日期:1992-01-01 00:00:00

  • Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials.

    abstract:OBJECTIVES:This study aimed to evaluate any correlations between baseline creatinine clearance and the development of grade 3/4 toxicities during treatment within oncology phase I trials of molecularly targeted agents where entry criteria mandate a serum creatinine of ≤ 1.5 × the upper limit of normal. METHODS:Documen...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341152

    authors: Basu B,Vitfell-Pedersen J,Moreno Garcia V,Puglisi M,Tjokrowidjaja A,Shah K,Malvankar S,Anghan B,de Bono JS,Kaye SB,Molife LR,Banerji U

    更新日期:2012-01-01 00:00:00

  • Clinical characteristics and outcomes of lung cancer with pulmonary embolism.

    abstract:BACKGROUND:Cancer patients have a higher risk for thrombosis that is usually related to advanced stage and poor prognosis. This study aimed to identify the clinical picture and outcome of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) patients with pulmonary embolism (PE). PATIENTS AND METHODS:Fr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000229503

    authors: Chuang YM,Yu CJ

    更新日期:2009-01-01 00:00:00

  • Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature.

    abstract::Primary pancreatic lymphoma (PL) is an extremely rare disease, and large-scale studies are rarely performed even in Western countries, in which all cases of PL reported to date were of the B-cell type. Little information regarding PL is available in Japan. Nineteen cases of PL were collected through a nationwide study...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000058528

    authors: Nishimura R,Takakuwa T,Hoshida Y,Tsujimoto M,Aozasa K

    更新日期:2001-01-01 00:00:00

  • Elliptinium acetate in metastatic breast cancer--a phase II study.

    abstract::Thirty-five patients with metastatic breast cancer who had received one or two prior chemotherapeutic regimens were treated with elliptinium acetate at a dose of 80 mg/m2 for 3 days every 3 weeks. Of the 33 patients evaluable for response, 1 patient achieved complete remission, 4 achieved partial responses (15% overal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226797

    authors: Buzdar AU,Hortobagyi GN,Esparza LT,Holmes FA,Ro JS,Fraschini G,Lichtiger B

    更新日期:1990-01-01 00:00:00

  • Cytogenetic testing of mutagenic and radioprotective effects of mesna.

    abstract::The effects of mesna (sodium 2-mercaptoethane-sulfonate) on the frequency of sister chromatid exchange (SCE) and chromosomal aberrations were studied in PHA-stimulated lymphocytes in vitro. Our data give no evidence for either an increase of SCE or chromosomal aberrations and, thus, do not suggest a mutagenic or cance...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225745

    authors: Becher R,Kakati S,Gibas Z,Sandberg AA

    更新日期:1983-01-01 00:00:00

  • Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

    abstract:BACKGROUND:Sorafenib, a multitargeted tyrosine kinase inhibitor, is now the treatment of choice for systemic therapy of patients with advanced hepatocellular carcinoma (HCC). Herein, we present the clinical characteristics and outcomes of patients with advanced HCC who were treated with sorafenib. METHODS:Data of 201 ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000327591

    authors: Baek KK,Kim JH,Uhm JE,Park SH,Lee J,Park JO,Park YS,Kang WK,Lim HY

    更新日期:2011-01-01 00:00:00

  • HER-targeted tyrosine-kinase inhibitors.

    abstract::Improved understanding of tumor biology has led to the identification of numerous growth factors that are involved in malignant transformation and tumor progression. Many of these factors induce cellular responses through receptors with intrinsic tyrosine kinase (TK) activity. Therefore, inhibiting receptor TK activit...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000066198

    authors: Baselga J,Hammond LA

    更新日期:2002-01-01 00:00:00

  • Concurrent chemoradiotherapy with a novel fluoropyrimidine, S-1, and cisplatin for locally advanced esophageal cancer: long-term results of a phase II trial.

    abstract:OBJECTIVES:A phase II study was performed to investigate the safety and efficacy of concurrent chemoradiotherapy (CCRT) combined with an orally active fluoropyrimidine, S-1, plus cisplatin for locally advanced esophageal cancer (LAEC). METHODS:CCRT comprised 2 courses, a 30-Gy radiotherapy over 3 weeks plus daily oral...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000348383

    authors: Iwase H,Shimada M,Tsuzuki T,Hirashima N,Okeya M,Hibino Y,Ryuge N,Yokoi M,Kida Y,Kuno T,Tanaka Y,Kato B,Esaki M,Urata N,Kato E

    更新日期:2013-01-01 00:00:00

  • Inhibitory action of aminoglutethimide on DMBA-induced mammary carcinogenesis.

    abstract::The present communication reports the inhibitory action of aminoglutethimide on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced mammary carcinogenesis in virgin female Holtzman rats. When 20 mg of DMBA is given to the rats and maintained on normal diet for 32 weeks, approximately 70% of the animals develop mammary tum...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226013

    authors: Rao AR,Das MG,Das P

    更新日期:1985-01-01 00:00:00

  • Initial experience with Healthport miniMax and other peripheral arm ports in patients with advanced gastrointestinal malignancy.

    abstract::While central ports are located at the chest, peripheral ports (PP) are inserted at the patients' forearms. Two new PPs (Healthport miniMax((R)) and Bard Titan Low Profile Port) and two well-established types (Port-A-Cath((R)) P.A.S. Port and PeriPort(TM) peripheral access system) were tested. 125 patients were given ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012059

    authors: Lersch C,Eckel F,Sader R,Paschalidis M,Zeilhofer F,Schulte-Frohlinde E,Theiss W

    更新日期:1999-11-01 00:00:00

  • Impact of interferon therapy after curative treatment of hepatocellular carcinoma.

    abstract::Primary and secondary prevention of hepatocellular carcinoma (HCC) which has become endemic worldwide in recent years are the most important issues in reducing mortality of HCC patients. Among several compounds previously reported for secondary prevention, treatment with interferon (IFN) is widely applied and shows en...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000173422

    authors: Kudo M

    更新日期:2008-01-01 00:00:00

  • Multiple persistent keratoacanthomas.

    abstract::A unique case of multiple keratoacanthomas is described, with involvement of the face and lower extremities with persistent lesions clinically and histologically diagnostic of keratoacanthomas. The lower extremity lesions appear as giant keratoacanthomas, with evolution into a distinctive confluent plaque. This import...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225359

    authors: Schwartz RA

    更新日期:1979-01-01 00:00:00

  • Association of Fatigue Intensification with Cognitive Impairment during Radiation Therapy for Prostate Cancer.

    abstract:PURPOSE:Cancer-related fatigue is a common complaint during cancer treatment and is often associated with cognitive impairment. This study examined cognitive deficits that were associated with fatigue symptoms during external-beam radiation therapy (EBRT) in men with localized prostate cancer. METHODS:A total of 36 pa...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000487081

    authors: Feng LR,Espina A,Saligan LN

    更新日期:2018-01-01 00:00:00

  • Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.

    abstract::The levels of bone-specific alkaline phosphatase (BALP) in plasma and tumour tissue samples of 20 Chinese patients with osteosarcoma in Hong Kong were measured by the wheat germ lectin precipitation technique. The plasma BALP levels in these patients were significantly higher than those of the normal subjects (p < 0.0...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227573

    authors: Liu PP,Leung KS,Kumta SM,Lee KM,Fung KP

    更新日期:1996-07-01 00:00:00

  • Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

    abstract::In order to determine the operative indications of three-field lymph node dissection of esophageal cancer, attempts were made to collect data concerning procedures performed between 1983 and 1989 in major institutions in Japan, and the results from institutions performing three-field or two-field lymph node dissection...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226971

    authors: Isono K,Sato H,Nakayama K

    更新日期:1991-01-01 00:00:00